INVST’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

INVST’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256K	Sell	2,001 -631	-24%	-$78.8K	0.03%	300
2025 Q4	$321K	Sell	2,632 -160	-6%	-$18.3K	0.03%	265
2025 Q3	$280K	Hold	2,792	–	–	0.03%	271
2025 Q2	$232K	Sell	2,792 -400	-13%	-$31.9K	0.03%	278
2025 Q1	$259K	Sell	3,192 -340	-10%	-$30.4K	0.04%	255
2024 Q4	$318K	Buy	3,532 +725	+26%	+$70.2K	0.04%	202
2024 Q3	$277K	Buy	2,807 +160	+6%	+$15.7K	0.03%	209
2024 Q2	$246K	Buy	+2,647	New	+$237K	0.03%	232

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

INVST's XBI Position: Q1 2026 in Review

INVST reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 24% in Q1 2026, selling an estimated $78.8K and leaving 2,001 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #300.

INVST first reported a position in XBI in Q2 2024 and has held it in 8 quarters since. The position peaked at $321K in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

INVST held 2,001 shares of State Street SPDR S&P Biotech ETF worth $256K as of Q1 2026.
INVST sold 631 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $78.8K.
State Street SPDR S&P Biotech ETF made up 0.03% of INVST's portfolio in Q1 2026, its #300 holding.
INVST first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 8 quarters since.
INVST's State Street SPDR S&P Biotech ETF position peaked at $321K in Q4 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on INVST's 13F filing for Q1 2026, filed 13 May 2026.